Do you require clinically relevant Mesenchymal Stem Cells for your research?
Then the last Renovos’ Osteoarthritic Mesenchymal Stem Cells remaining in the UK might be of interest. And it is now on offer!
Renovos’ MSCs have unique stem cell populations within a clinically relevant age range and with clinical presentations.
Offer Details
Get 30% off Mesenchymal Stem Cells from Osteoarthritic Donors – pack sizes 500,000 cells (REN-OA-500) or 1 million cells (REN-OA-1M).
You can claim this offer by mentioning promo code ‘RenovosMSC’ when contacting us.
This offer is valid whilst stock lasts!
About Renovos’ Mesenchymal Stem Cells
Mesenchymal stem cells, MSCs, or skeletal stem cells, of bone marrow origin, have been used as research tools for decades and within the past 10 years progressed to hundreds of clinical trials for various regenerative and immunomodulatory approaches. The MSC research field is expanding rapidly, however, the outcomes of various in vitro and in vivo studies are not directly comparable due to variability in the stem cell source used, purity, or even irrelevant donor selection.
Renovos offers heterogeneous populations of MSCs, from osteoarthritic donor cohorts, for biologics and biomaterial testing.
Advantages of Renovos’ MSCs:
- Clinically relevant age range for testing therapeutics/biomaterials designed for the elderly, adults or adolescents
- Donors with clinical presentations – osteoarthritis (with other orthopaedic cohorts in the pipeline), as a suitable model for relevant drug/biomaterial testing
- Early passages and guaranteed cell expansion – P2 stocks, >10 population doublings under optimal conditions
- Detailed flow cytometric analysis – for expression of common mesenchymal stem/progenitor cell markers, including for STRO-1, CD73, CD90, CD105 and lack of CD45
- Multipotency – tested for osteo-, chondro- and adipogenic differentiation in vitro
- Pathogen-free – HBV/HCV/HIV, bacteria, mycoplasma and fungi-free
About Renovos
Renovos commercialises the world-class research undertaken at the University of Southampton and draws on over 50 years of combined expertise in skeletal stem cells, translational orthopaedic research, and materials for tissue repair.
Caltag Medsystems is the distributor of Renovos products in the UK.